Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Webinar: Mount Sinai Scientists Design Multiplex COVID-19 Antibody Test
Implementing xMAP® Technology allows for faster, more accurate results
When the global outbreak hit the US, the Icahn School of Medicine at Mount Sinai in New York City published some of the earliest COVID-19 studies in the US. It’s no surprise then that scientists at Mount Sinai were among the first to develop an antibody test. Using xMAP® Technology to design this test allowed them to make the most of its high-throughput multiplexing capabilities, fast results, and low sample input requirements.
Continue Reading >
Designed for use on the ARIES® System, the ARIES® SARS-CoV- 2 Assay is a moderate-complexity, sample-to-answer test that enables targeted SARS-CoV-2 detection. ARIES® consolidates the assay steps into a single workflow and reduces turnaround time with STAT and random batch testing.
Luminex Corporation Declares Third Quarter Cash Dividend